These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 15939051)

  • 21. Cholesterol reduction and atherosclerosis inhibition by bezafibrate in low-density lipoprotein receptor knockout mice.
    Inaba T; Yagyu H; Itabashi N; Tazoe F; Fujita N; Nagashima S; Okada K; Okazaki M; Furukawa Y; Ishibashi S
    Hypertens Res; 2008 May; 31(5):999-1005. PubMed ID: 18712055
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generation and characterization of a humanized PPARδ mouse model.
    Gross B; Hennuyer N; Bouchaert E; Rommens C; Grillot D; Mezdour H; Staels B
    Br J Pharmacol; 2011 Sep; 164(1):192-208. PubMed ID: 21426320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of peroxisome proliferator-activated receptor δ inhibits human macrophage foam cell formation and the inflammatory response induced by very low-density lipoprotein.
    Bojic LA; Sawyez CG; Telford DE; Edwards JY; Hegele RA; Huff MW
    Arterioscler Thromb Vasc Biol; 2012 Dec; 32(12):2919-28. PubMed ID: 23023367
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peroxisome proliferator-activated receptor {delta} regulates inflammation via NF-{kappa}B signaling in polymicrobial sepsis.
    Zingarelli B; Piraino G; Hake PW; O'Connor M; Denenberg A; Fan H; Cook JA
    Am J Pathol; 2010 Oct; 177(4):1834-47. PubMed ID: 20709805
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incremental replacement of saturated fats by n-3 fatty acids in high-fat, high-cholesterol diets reduces elevated plasma lipid levels and arterial lipoprotein lipase, macrophages and atherosclerosis in LDLR-/- mice.
    Chang CL; Torrejon C; Jung UJ; Graf K; Deckelbaum RJ
    Atherosclerosis; 2014 Jun; 234(2):401-9. PubMed ID: 24747115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of macrophage-derived apolipoprotein E on hyperlipidemia and atherosclerosis of LDLR-deficient mice.
    Shi W; Wang X; Wong J; Hedrick CC; Wong H; Castellani LW; Lusis AJ
    Biochem Biophys Res Commun; 2004 Apr; 317(1):223-9. PubMed ID: 15047172
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Expressions of atherosclerosis-related genes in aorta in young apoE/LDLR double knockout mice].
    Dai XD; Yin M; Jing W; DU HQ; Ye HY; Shang YJ; Zhang L; Zou YY; Qu ZP; Pan J
    Sheng Li Xue Bao; 2008 Feb; 60(1):43-50. PubMed ID: 18288357
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of soluble epoxide hydrolase alleviated atherosclerosis by reducing monocyte infiltration in Ldlr(-/-) mice.
    Li D; Liu Y; Zhang X; Lv H; Pang W; Sun X; Gan LM; Hammock BD; Ai D; Zhu Y
    J Mol Cell Cardiol; 2016 Sep; 98():128-37. PubMed ID: 27496380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. KRP-203, sphingosine 1-phosphate receptor type 1 agonist, ameliorates atherosclerosis in LDL-R-/- mice.
    Potì F; Gualtieri F; Sacchi S; Weißen-Plenz G; Varga G; Brodde M; Weber C; Simoni M; Nofer JR
    Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1505-12. PubMed ID: 23640484
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myeloid cell-specific ATP-binding cassette transporter A1 deletion has minimal impact on atherogenesis in atherogenic diet-fed low-density lipoprotein receptor knockout mice.
    Bi X; Zhu X; Gao C; Shewale S; Cao Q; Liu M; Boudyguina E; Gebre AK; Wilson MD; Brown AL; Parks JS
    Arterioscler Thromb Vasc Biol; 2014 Sep; 34(9):1888-99. PubMed ID: 24833800
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Arginase I induction by modified lipoproteins in macrophages: a peroxisome proliferator-activated receptor-gamma/delta-mediated effect that links lipid metabolism and immunity.
    Gallardo-Soler A; Gómez-Nieto C; Campo ML; Marathe C; Tontonoz P; Castrillo A; Corraliza I
    Mol Endocrinol; 2008 Jun; 22(6):1394-402. PubMed ID: 18323470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Macrophage ABCG1 deletion disrupts lipid homeostasis in alveolar macrophages and moderately influences atherosclerotic lesion development in LDL receptor-deficient mice.
    Out R; Hoekstra M; Hildebrand RB; Kruit JK; Meurs I; Li Z; Kuipers F; Van Berkel TJ; Van Eck M
    Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2295-300. PubMed ID: 16857950
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of peroxisome proliferator-activated receptor delta inhibits streptozotocin-induced diabetic nephropathy through anti-inflammatory mechanisms in mice.
    Matsushita Y; Ogawa D; Wada J; Yamamoto N; Shikata K; Sato C; Tachibana H; Toyota N; Makino H
    Diabetes; 2011 Mar; 60(3):960-8. PubMed ID: 21270242
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HOE 402 lowers serum cholesterol levels by reducing VLDL-lipid production, and not by induction of the LDL receptor, and reduces atherosclerosis in wild-type and LDL receptor-deficient mice.
    Draijer R; Volger OL; Dahlmans VE; de Wit EC; Havekes LM; Princen HM
    Biochem Pharmacol; 2002 May; 63(9):1755-61. PubMed ID: 12007578
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Macrophage alternative activation confers protection against lipotoxicity-induced cell death.
    Dai L; Bhargava P; Stanya KJ; Alexander RK; Liou YH; Jacobi D; Knudsen NH; Hyde A; Gangl MR; Liu S; Lee CH
    Mol Metab; 2017 Oct; 6(10):1186-1197. PubMed ID: 29031719
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PPARdelta regulates multiple proinflammatory pathways to suppress atherosclerosis.
    Barish GD; Atkins AR; Downes M; Olson P; Chong LW; Nelson M; Zou Y; Hwang H; Kang H; Curtiss L; Evans RM; Lee CH
    Proc Natl Acad Sci U S A; 2008 Mar; 105(11):4271-6. PubMed ID: 18337509
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PPARdelta ligand L-165041 ameliorates Western diet-induced hepatic lipid accumulation and inflammation in LDLR-/- mice.
    Lim HJ; Park JH; Lee S; Choi HE; Lee KS; Park HY
    Eur J Pharmacol; 2009 Nov; 622(1-3):45-51. PubMed ID: 19766624
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of heterozygous lipoprotein lipase deficiency on diet-induced atherosclerosis in mice.
    Semenkovich CF; Coleman T; Daugherty A
    J Lipid Res; 1998 Jun; 39(6):1141-51. PubMed ID: 9643345
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LCAT modulates atherogenic plasma lipoproteins and the extent of atherosclerosis only in the presence of normal LDL receptors in transgenic rabbits.
    Brousseau ME; Kauffman RD; Herderick EE; Demosky SJ; Evans W; Marcovina S; Santamarina-Fojo S; Brewer HB; Hoeg JM
    Arterioscler Thromb Vasc Biol; 2000 Feb; 20(2):450-8. PubMed ID: 10669643
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design, Synthesis, and Anti-Inflammatory Evaluation of a Novel PPARδ Agonist with a 4-(1-Pyrrolidinyl)piperidine Structure.
    Kato T; Fukao K; Ohara T; Naya N; Tokuyama R; Muto S; Fukasawa H; Itai A; Matsumura KI
    J Med Chem; 2023 Aug; 66(16):11428-11446. PubMed ID: 37552807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.